#nonclear - Twitter Hashtag

over 1 year ago

Was wonderful seeing dear friends & colleagues at the @ScrippsHealth #OncologyReview where I gave an update on #nonclear #kidneycancer. Got to catch up with my fmr @UCLAHealth coresident #DrRenaCallahan as well as @dradityabardia. Also finally reunited with @datsunian who provides tremendous #cardiooncology care at @UCLA. @mpkosty also in the house! Stay tuned tomorrow for a terrific #prostatecancer update from @TDorffOnc.

montypal's tweet photo. Was wonderful seeing dear friends & colleagues at the @ScrippsHealth #OncologyReview where I gave an update on #nonclear #kidneycancer. Got to catch up with my fmr @UCLAHealth coresident #DrRenaCallahan as well as @dradityabardia. Also finally reunited with @datsunian who provides tremendous #cardiooncology care at @UCLA. @mpkosty also in the house! Stay tuned tomorrow for a terrific #prostatecancer update from @TDorffOnc.

2

43

9

2

3K

Sumanta K. Pal, MD, FASCO

@montypal

almost 2 years ago

Comprehensive presentation from @maughanonc @huntsmancancer on current & ongoing trials in #nonclear #kidneycancer at #IKCSNA24. Ben is PI of @SWOG 2200, a study we need support for! @PrimoLaraMD @DrVaishampayan @KidneyCancerDoc

montypal's tweet photo. Comprehensive presentation from @maughanonc @huntsmancancer on current & ongoing trials in #nonclear #kidneycancer at #IKCSNA24. Ben is PI of @SWOG 2200, a study we need support for! @PrimoLaraMD @DrVaishampayan @KidneyCancerDoc https://t.co/RF6BJDI1qa

1

33

20

3

3K

Kidney Cancer @KidneyCancer

almost 2 years ago

Thank you @montypal for this succinct and necessary analysis of the state of standard of care treatment for #nonclear and #papillary #kidneycancer. Thanks also for highlighting our trial finder tool. Critical for any patient, esp those still not well advised about them. #ESMO24

Sumanta K. Pal, MD, FASCO

@montypal

almost 2 years ago

Patients with #papillary and #nonclear #kidneycancer deserve the utmost thanks for participating in these efforts. I would also like to thank groups like @kcCURE & @KidneyCancer who have brilliant trial-finding tools online! If you are at #ESMO24 & would like to continue this dialogue in person, DM me! (10/n)

montypal's tweet photo. Patients with #papillary and #nonclear #kidneycancer deserve the utmost thanks for participating in these efforts. I would also like to thank groups like @kcCURE & @KidneyCancer who have brilliant trial-finding tools online! If you are at #ESMO24 & would like to continue this dialogue in person, DM me! (10/n)

0

16

6

2

4K

0

14

6

0

2K

Sumanta K. Pal, MD, FASCO

@montypal

almost 2 years ago

Patients with #papillary and #nonclear #kidneycancer deserve the utmost thanks for participating in these efforts. I would also like to thank groups like @kcCURE & @KidneyCancer who have brilliant trial-finding tools online! If you are at #ESMO24 & would like to continue this dialogue in person, DM me! (10/n)

0

16

6

2

4K

Sumanta K. Pal, MD, FASCO

@montypal

almost 2 years ago

So what are those #randomized trials? I've summarized them here. #PAPMET2, #STELLAR304, #SAMETA & several others require our attention as a community. It's imperative that we definitively establish the role of TKI/IO regimens for #papillary #kidneycancer & other #nonclear cell types. (9/n)

montypal's tweet photo. So what are those #randomized trials? I've summarized them here. #PAPMET2, #STELLAR304, #SAMETA & several others require our attention as a community. It's imperative that we definitively establish the role of TKI/IO regimens for #papillary #kidneycancer & other #nonclear cell types. (9/n)

1

6

3

1

654

Sumanta K. Pal, MD, FASCO

@montypal

almost 2 years ago

So what is the current standard for #nonclear cell #kidneycancer, and perhaps more specifically #papillary? @SWOG 1500 showed that we can do randomized studies in this space, but many of our dialogues today are fueled by single arm experiences. @neerajaiims @BradMcG04 & I (along with others) have looked at #cabozantinib with #atezolizumab, and @KellyNFitz recently updated data for #cabozantinib with #nivolumab in @EUplatinum. Impressive RRs & both with a RR in #papillary of 47%. (3/n)

montypal's tweet photo. So what is the current standard for #nonclear cell #kidneycancer, and perhaps more specifically #papillary? @SWOG 1500 showed that we can do randomized studies in this space, but many of our dialogues today are fueled by single arm experiences. @neerajaiims @BradMcG04 & I (along with others) have looked at #cabozantinib with #atezolizumab, and @KellyNFitz recently updated data for #cabozantinib with #nivolumab in @EUplatinum. Impressive RRs & both with a RR in #papillary of 47%. (3/n)

1

11

2

0

875

Sumanta K. Pal, MD, FASCO

@montypal

almost 2 years ago

🧵Huge congrats to @PBarataMD @caseccc who drove this important analysis of @SWOG 1500, published just ahead of #ESMO24 in @JCO_ASCO. Lots of dialogue here in #Barcelona around management of #nonclear #kidneycancer; I think this paper & data from #SUNNIFORECAST are impt parts of the dialogue ... (1/n)

montypal's tweet photo. 🧵Huge congrats to @PBarataMD @caseccc who drove this important analysis of @SWOG 1500, published just ahead of #ESMO24 in @JCO_ASCO. Lots of dialogue here in #Barcelona around management of #nonclear #kidneycancer; I think this paper & data from #SUNNIFORECAST are impt parts of the dialogue ... (1/n)

3

70

28

11

6K

Top Tweets for #nonclear

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users